BETA: Please send your feedback!

Reata Pharmaceuticals

NAS:RETA

Pharmaceuticals: Major

$0
SMALL cap
$89.77 (2.92%)
61.0802%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5

About

Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its products include cardiovascular, rare diseases, immune-oncology, and ophthalmology. The company was founded by J. Warren Huff on September 1, 2002 and is headquartered in Irving, TX.
website

Headquarters

2801 Gateway Drive
Suite 150
Irving, TX 75063

Executives

Name Title Gender
W. Christian Wigley, PhD Vice President-Research & Founding Scientist Male
Michael D. Wortley Chief Legal Officer & Vice President Male
J. Warren Huff Chairman, Chief Executive Officer & President Male
Jason Wilson, MBA, CPA Chief Financial Officer & Vice President-Strategy Male
Jef Karel de Brabander Founder Male
Waldemar Priebe, PhD Founder Male
Philip J. Thomas Founder Male
Colin Meyer, MD, MBA Chief Medical Officer & VP-Product Development Male
Thomas C. SŸdhof, MD Founder Male
Joel Proksch, PhD Vice President-Regulatory & Development Male

Mindful Investing Summary

  • 1
  • 2
  • 3
  • 4
  • 5
  • Carbon Footprint N/A
  • Pollution Prevention N/A
  • Water Conservation N/A
  • Data & Privacy Protection N/A
  • Consumer Health, Wellness & Safety N/A
  • Employee Ownership, Satisfaction, Benefits & Pay N/A
  • Workplace Health and Safety N/A
  • Integrity of Corporate Governance N/A
  • Ethical Practices N/A
  • Usage of Conflict Materials N/A
  • Forced Labor N/A
  • Diversity of Corporate Leadership 1

Reata Pharmaceuticals - Competitors and Related Companies

How Reata Pharmaceuticals stacks up to its peers in the Pharmaceuticals: Major industry or with competing business segments.

Reata Pharmaceuticals

NAS:RETA

Pharmaceuticals: Major

$0
SMALL cap
$89.77 (2.92%)
61.0802%
since start of 2019
  • 1
  • Carbon Footprint
  • Pollution Prevention
  • Water Conservation
  • Data Privacy
  • Consumer Health
  • Employee Satisfaction
  • Workplace Safety
  • Corp Gov
  • Ethical Practices
  • Conflict Materials
  • Forced Labor
  • Gender Diversity
  • 1
  • CF
  • PP
  • WC
  • DP
  • CH
  • ES
  • WS
  • CG
  • EP
  • CM
  • FL
  • GD
  • 1
  • 2
  • 3
  • 4
  • 5
Loading…